Hirokazu Nakayama, Hiromitsu Iizuka, Toshiaki Kato, & Kensuke Usuki. (2023). Is higher lymphocyte count a potential strategy for preventing chronic kidney disease in patients receiving long-term dasatinib treatment? BMC.
Chicago Style (17th ed.) CitationHirokazu Nakayama, Hiromitsu Iizuka, Toshiaki Kato, and Kensuke Usuki. Is Higher Lymphocyte Count a Potential Strategy for Preventing Chronic Kidney Disease in Patients Receiving Long-term Dasatinib Treatment? BMC, 2023.
MLA (9th ed.) CitationHirokazu Nakayama, et al. Is Higher Lymphocyte Count a Potential Strategy for Preventing Chronic Kidney Disease in Patients Receiving Long-term Dasatinib Treatment? BMC, 2023.
Warning: These citations may not always be 100% accurate.